{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T04:58:46Z","timestamp":1790657926288,"version":"4.1.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,4]],"date-time":"2023-12-04T00:00:00Z","timestamp":1701648000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81241094"],"award-info":[{"award-number":["81241094"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["8167060249"],"award-info":[{"award-number":["8167060249"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2016HM13"],"award-info":[{"award-number":["ZR2016HM13"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.heliyon.2023.e23438","type":"journal-article","created":{"date-parts":[[2023,12,11]],"date-time":"2023-12-11T15:54:29Z","timestamp":1702310069000},"page":"e23438","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Autotaxin: A Potential biomarker for primary biliary cholangitis"],"prefix":"10.1016","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9568-6898","authenticated-orcid":false,"given":"Yifei","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingqian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Zang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qixuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenyang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3436-4542","authenticated-orcid":false,"given":"Bin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.heliyon.2023.e23438_bib1","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1002\/hep.30145","article-title":"Primary biliary cholangitis: 2018 practice guidance from the American association for the study of liver diseases","volume":"69","author":"Lindor","year":"2018","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.heliyon.2023.e23438_bib2","first-page":"4245","article-title":"ATX-LPA axis facilitates estrogen-induced endometrial cancer cell proliferation via MAPK\/ERK signaling pathway","volume":"17","author":"Zhang","year":"2018","journal-title":"Mol. Med. Rep."},{"issue":"8","key":"10.1016\/j.heliyon.2023.e23438_bib3","article-title":"Roles for lysophosphatidic acid signaling in vascular development and disease","volume":"1865","author":"Smyth","year":"2020","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"},{"issue":"1","key":"10.1016\/j.heliyon.2023.e23438_bib4","doi-asserted-by":"crossref","DOI":"10.1186\/s12974-020-01809-1","article-title":"MAPK signaling determines lysophosphatidic acid (LPA)-induced inflammation in microglia","volume":"17","author":"Plastira","year":"2020","journal-title":"J. Neuroinflammation"},{"issue":"2","key":"10.1016\/j.heliyon.2023.e23438_bib5","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1096\/fj.13-232868","article-title":"Integrin\u2010mediated cell surface recruitment of autotaxin promotes persistent directional cell migration","volume":"28","author":"Wu","year":"2013","journal-title":"Faseb. J."},{"issue":"11","key":"10.1016\/j.heliyon.2023.e23438_bib6","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.3390\/cancers11111626","article-title":"Deregulated lysophosphatidic acid metabolism and signaling in liver cancer","volume":"11","author":"Kaffe","year":"2019","journal-title":"Cancers"},{"issue":"9","key":"10.1016\/j.heliyon.2023.e23438_bib7","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1136\/gutjnl-2017-315259","article-title":"The British Society of Gastroenterology\/UK-PBC primary biliary cholangitis treatment and management guidelines","volume":"67","author":"Hirschfield","year":"2018","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.heliyon.2023.e23438_bib8","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/BF00432479","article-title":"Staging of chronic nonsuppurative destructive cholangitis (syndrome of primary biliary cirrhosis)","volume":"379","author":"Ludwig","year":"1978","journal-title":"Virchows Arch. A Pathol. Anat. Histol."},{"issue":"6","key":"10.1016\/j.heliyon.2023.e23438_bib9","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/j.jhep.2017.02.013","article-title":"Role of endoscopy in primary sclerosing cholangitis: European society of gastrointestinal endoscopy (ESGE) and European association for the study of the liver (EASL) clinical guideline","volume":"66","author":"Aabakken","year":"2017","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e23438_bib10","doi-asserted-by":"crossref","DOI":"10.1186\/1471-230X-10-100","article-title":"Prevalence of primary biliary cirrhosis in adults referring hospital for annual health check-up in Southern China","volume":"10","author":"Liu","year":"2010","journal-title":"BMC Gastroenterol."},{"key":"10.1016\/j.heliyon.2023.e23438_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/MOG.0000000000000257","article-title":"Primary biliary cholangitis in China","author":"Wang","year":"2016","journal-title":"Curr. Opin. Gastroenterol."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e23438_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3350\/cmh.2020.0028","article-title":"Current understanding of primary biliary cholangitis","volume":"27","author":"Tanaka","year":"2021","journal-title":"Clin. Mol. Hepatol."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e23438_bib13","article-title":"Underestimated male prevalence of primary biliary cholangitis in China: results of a 16-yr cohort study involving 769 patients","volume":"7","author":"Fan","year":"2017","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.heliyon.2023.e23438_bib14","first-page":"343","article-title":"[Differential characteristics of AMA-M2 autoantibody in primary biliary cirrhosis and non-PBC patients]","volume":"23","author":"Sun","year":"2015","journal-title":"Zhonghua Gan Zang Bing Za Zhi"},{"issue":"7","key":"10.1016\/j.heliyon.2023.e23438_bib15","doi-asserted-by":"crossref","first-page":"926","DOI":"10.4254\/wjh.v7.i7.926","article-title":"Primary biliary cirrhosis: pathophysiology, clinical presentation and therapy","volume":"7","author":"Purohit","year":"2015","journal-title":"World J. Hepatol."},{"issue":"7","key":"10.1016\/j.heliyon.2023.e23438_bib16","doi-asserted-by":"crossref","first-page":"3305","DOI":"10.1007\/s10620-021-07122-y","article-title":"Anti-mitochondrial antibody-negative primary biliary cholangitis is part of the same spectrum of classical primary biliary cholangitis","volume":"67","author":"Can\u00e7ado","year":"2022","journal-title":"Dig. Dis. Sci."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e23438_bib17","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.cld.2007.11.008","article-title":"Anti-mitochondrial antibody\u2013negative primary biliary cirrhosis","volume":"12","author":"Selmi","year":"2008","journal-title":"Clin. Liver Dis."},{"issue":"5","key":"10.1016\/j.heliyon.2023.e23438_bib18","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1111\/apt.13927","article-title":"The risk predictive values of UK-PBC and GLOBE scoring system in Chinese patients with primary biliary cholangitis: the additional effect of anti-gp210","volume":"45","author":"Yang","year":"2017","journal-title":"Aliment. Pharmacol. Ther."},{"issue":"5","key":"10.1016\/j.heliyon.2023.e23438_bib19","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.clinre.2016.06.001","article-title":"The diagnosis of antimitochondrial antibody-negative primary biliary cholangitis","volume":"40","author":"Ozaslan","year":"2016","journal-title":"Clinics and Research in Hepatology and Gastroenterology"},{"issue":"6","key":"10.1016\/j.heliyon.2023.e23438_bib20","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/cmi.2017.140","article-title":"Comprehensive review of autoantibodies in patients with hyper-IgM syndrome","volume":"15","author":"Barbouche","year":"2018","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.heliyon.2023.e23438_bib21","series-title":"Early Prognostic Utility of Gp210 Antibody-Positive Rate in Primary Biliary Cholangitis: A Meta-Analysis","first-page":"1","author":"Huang","year":"2019"},{"issue":"2","key":"10.1016\/j.heliyon.2023.e23438_bib22","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1111\/liv.12690","article-title":"Anti-kelch-like 12 and anti-hexokinase 1: novel autoantibodies in primary biliary cirrhosis","volume":"35","author":"Norman","year":"2014","journal-title":"Liver Int."},{"key":"10.1016\/j.heliyon.2023.e23438_bib23","series-title":"Detection of Anti-kelch-like 12 and Anti-hexokinase 1 Antibodies in Primary Biliary Cholangitis Patients in China","author":"Bin","year":"2020"},{"issue":"9","key":"10.1016\/j.heliyon.2023.e23438_bib24","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1515\/cclm-2020-0122","article-title":"Evaluation of a novel extended automated particle-based multi-analyte assay for the detection of autoantibodies in the diagnosis of primary biliary cholangitis","volume":"58","author":"Villalta","year":"2020","journal-title":"Clin. Chem. Lab. Med."},{"issue":"12","key":"10.1016\/j.heliyon.2023.e23438_bib25","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1002\/oby.21232","article-title":"Serum Autotaxin\/ENPP2 correlates with insulin resistance in older humans with obesity","volume":"23","author":"Reeves","year":"2015","journal-title":"Obesity"},{"issue":"23\u201324","key":"10.1016\/j.heliyon.2023.e23438_bib26","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1016\/j.cca.2012.07.014","article-title":"Autotaxin in liver fibrosis","volume":"413","author":"Ikeda","year":"2012","journal-title":"Clin. Chim. Acta"},{"issue":"8","key":"10.1016\/j.heliyon.2023.e23438_bib27","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.autrev.2016.03.019","article-title":"Autotaxin, pruritus and primary biliary cholangitis (PBC)","volume":"15","author":"Sun","year":"2016","journal-title":"Autoimmun. Rev."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e23438_bib28","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/jgh.15114","article-title":"Association of serum autotaxin levels with liver fibrosis in patients pretreatment and posttreatment with chronic hepatitis C","volume":"36","author":"Takemura","year":"2020","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"S14","key":"10.1016\/j.heliyon.2023.e23438_bib29","doi-asserted-by":"crossref","first-page":"S1740","DOI":"10.21037\/jtd.2019.04.62","article-title":"Pharmacotherapy and adjunctive treatment for idiopathic pulmonary fibrosis (IPF)","volume":"11","author":"Saito","year":"2019","journal-title":"J. Thorac. Dis."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e23438_bib30","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1515\/cclm-2017-0249","article-title":"The diagnostic accuracy of biomarkers for diagnosis of primary biliary cholangitis (PBC) in anti-mitochondrial antibody (AMA)-negative PBC patients: a review of literature","volume":"56","author":"de Liso","year":"2017","journal-title":"Clin. Chem. Lab. Med."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e23438_bib31","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-26531-0","article-title":"Serum autotaxin is a useful disease progression marker in patients with primary biliary cholangitis","volume":"8","author":"Joshita","year":"2018","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e23438_bib32","doi-asserted-by":"crossref","DOI":"10.1038\/srep30847","article-title":"Serum autotaxin is a marker of the severity of liver injury and overall survival in patients with cholestatic liver diseases","volume":"6","author":"Wunsch","year":"2016","journal-title":"Sci. Rep."}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844023106463?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844023106463?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T04:41:11Z","timestamp":1790656871000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844023106463"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S2405844023106463"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2023.e23438","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Autotaxin: A Potential biomarker for primary biliary cholangitis","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2023.e23438","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e23438"}}